Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Furnari

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Genes & Development|September 11, 2020
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stabilityAlison D Parisian, Tomoyuki Koga, Shunichiro Miki, et al.
Neuro-Oncology|April 17, 2018
Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker developmentTomoyuki Koga, Bin Li, Javier M Figueroa, et al.
Oncogene|June 13, 2000
IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutationK Reiss, J Y Wang, G Romano, et al.
Cancer Research|May 1, 1995
Loss of P16INK4 expression is frequent in high grade gliomasR Nishikawa, F B Furnari, H Lin, et al.
Neuro-Oncology|April 17, 2001
SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytesO Bögler, F B Furnari, A Kindler-Roehrborn, et al.
Disease Models & Mechanisms|February 14, 2024
Stem cell modeling of nervous system tumorsFrank B Furnari, Corina Anastasaki, Shan Bian, et al.
Molecular Cancer Research : MCR|June 23, 2011
MicroRNA-138 modulates DNA damage response by repressing histone H2AX expressionYemin Wang, Jen-Wei Huang, Ming Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastomaPaul H Huang, Akitake Mukasa, Rudy Bonavia, et al.
The Journal of Biological Chemistry|August 22, 2001
The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptorM Klingler-Hoffmann, M T Fodero-Tavoletti, K Mishima, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin ComplexRaghavendra Vadla, Shunichiro Miki, Brett Taylor, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Genes & Development|September 11, 2020
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stabilityAlison D Parisian, Tomoyuki Koga, Shunichiro Miki, et al.
Neuro-Oncology|April 17, 2018
Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker developmentTomoyuki Koga, Bin Li, Javier M Figueroa, et al.
Oncogene|June 13, 2000
IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutationK Reiss, J Y Wang, G Romano, et al.
Cancer Research|May 1, 1995
Loss of P16INK4 expression is frequent in high grade gliomasR Nishikawa, F B Furnari, H Lin, et al.
Neuro-Oncology|April 17, 2001
SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytesO Bögler, F B Furnari, A Kindler-Roehrborn, et al.
Disease Models & Mechanisms|February 14, 2024
Stem cell modeling of nervous system tumorsFrank B Furnari, Corina Anastasaki, Shan Bian, et al.
Molecular Cancer Research : MCR|June 23, 2011
MicroRNA-138 modulates DNA damage response by repressing histone H2AX expressionYemin Wang, Jen-Wei Huang, Ming Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastomaPaul H Huang, Akitake Mukasa, Rudy Bonavia, et al.
The Journal of Biological Chemistry|August 22, 2001
The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptorM Klingler-Hoffmann, M T Fodero-Tavoletti, K Mishima, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin ComplexRaghavendra Vadla, Shunichiro Miki, Brett Taylor, et al.
Pageof 12